BiVACOR® Total Artificial Heart Early Feasibility Study
Part of paid clinical trials in Phoenix, Arizona.
- Sponsor
- BiVACOR Inc.
- Study ID
- NCT06174103
- Status
- Recruiting
Conditions
- Biventricular Failure
- Heart Failure
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 70 Years
- Healthy Volunteers
- Not accepted
Interventions
- BiVACOR TAH System — DEVICEThe BiVACOR pump is an implantable rotary biventricular blood pump that uses magnetic levitation technology for increased durability to replace both ventricles of a failing heart. The device is intended to replace the diseased heart in patients suffering from heart failure to bridge the time to heart transplant.
Study Details
The purpose of this study is to assess the feasibility of using the BiVACOR Total Artificial Heart (TAH) System to support adult patients with severe biventricular heart failure, or univentricular heart failure in which left ventricular assist device (LVAD) support is not recommended, who require mechanical circulatory support to sustain life. The BiVACOR TAH System is intended for use as a bridge to transplant (BTT). Feasibility will be assessed by evaluating safety and performance of the BiVACOR TAH System in study subjects.
Key Dates
- Start date
- Jun 26, 2024
- Status verified
- Jul 2024
- Primary completion
- Aug 31, 2025
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 5 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- DEVICE_FEASIBILITY
Arms
- Experimental: BiVACOR TAHThe BiVACOR TAH System will be implanted as a bridge to transplant (BTT) for adults with severe irreversible biventricular heart failure or univentricular heart failure in which LVAD support is not recommended, and who are eligible for cardiac transplantation.
Primary Outcome Measure
Feasibility Endpoint [ Time Frame: 6 months or time of heart transplant (if prior to 6 months post pump implant) ]
Central Contacts
- Dennis Kirven804-461-1299
- Diane Covington480-794-0232
Locations (4)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Banner - University Medical Center Phoenix | Phoenix | Arizona | 85006 | |
| Duke University Hospital | Durham | North Carolina | 27710 | |
| The Christ Hospital | Cincinnati | Ohio | 45219 | |
| Texas Heart Institute / Baylor St. Luke's Medical Center | Houston | Texas | 77030 |
Find similar trials in Phoenix, AZ
By condition
By specialty
Related Studies
- Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy ProductsRecruiting · Medtronic · Birmingham, Alabama
- Identification of Genomic Predictors of Adverse Events After Cardiac SurgeryRecruiting · Brigham and Women's Hospital · Boston, Massachusetts
- Magnetic Resonance Elastography as a Method to Estimate Stiffness of Soft TissuesRecruiting · Arunark Kolipaka · Columbus, Ohio
- Get With The Guidelines-Heart Failure RegistryRecruiting · American Heart Association · Dallas, Texas